en

PRODUCT DETAIL

Temybric Ellipta 92 mikrogramov/55 mikrogramov/22 mikrogramov dávkovaný inhalačný prášok

Code 2247D
MA number EU/1/19/1378/001
Product Form: plv ido 1 x 1 inh./14 dávok (blis.Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: GlaxoSmithKline Trading Services Limited, Ireland
Therapeutic Class: 14 - BRONCHODILATANTIA, ANTIASTHMATICA
ATC:
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AL Adrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids
R03AL08 Vilanterol, umeclidinium bromide and fluticasone furoate
Shelf life: 24
Container: blister Al/Al
Route of admin.: Inhalation use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10c informed consent application
MA issued: 12.06.2019
Validity: 12.06.2024
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 25.07.2019
eu-flag.png sk-flag.png